跳至主要内容
临床试验/NCT01703663
NCT01703663已完成不适用

Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.

University of Michigan2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Apnea-hypopnea Index

研究概览

简要总结

Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke.

Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night.

Hypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation with nasal EPAP therapy compared with a control night.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults with an ischemic stroke (including TIA with infarction) within the prior 14 days

排除标准

  • Current use of any transnasal tube (eg dobhoff tube)
  • Current use of CPAP, mechanical ventilation, or supplemental oxygen
  • Known severe breathing disorders including hypercapnic respiratory failure, respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastinum
  • Severe heart disease (including severe heart failure)
  • Pathologically low blood pressure
  • An acute upper respiratory (including nasal, sinus or middle ear) inflammation or infection, or perforation of the ear drum
  • Sores, abrasions, or skin or mucosal irritation on or around the nose.
  • Known pregnancy
  • Inability to provide informed consent
  • Use of alpha blockers or short acting nitrates
  • Permanent pacemaker
  • Sustained non-sinus cardiac arrhythmia

结局指标

主要结局

Apnea-hypopnea Index

时间窗: night 1 and night 2

Apnea-hypopnea index (AHI) is the sum of the apneas and hypopneas and divided by the hours of sleep based on actigraphy. AHI values are typically categorized as 5-15/hr = mild; 15-30/hr = moderate; and \>= 30/h = severe. The prespecified primary (absolute) treatment effect is based on the linear repeated measures model.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Devin Brown

Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验